E.D. Salter

Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis.

Ronald P. Gladue, Laurie Carroll, Anthony J. Milici et al. · The Journal of Experimental Medicine · 1996 · 82 citations · Full text

Allergy Medicine, Immunology, Immune Regulation +19

2‐Amino‐4‐methylpyridine as a potent inhibitor of inducible NO synthase activity <i>in vitro</i> and <i>in vivo</i>

W. Stephen Faraci, A. Nagel, Kimberly A. Verdries et al. · British Journal of Pharmacology · 1996 · 64 citations · Full text

Molecular Pharmacology, Biochemistry, Potent Inhibitor +10

The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.

Henry J. Showell, E. R. Pettipher, Juan Cheng et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 63 citations

Striking Effect of Hydroxamic Acid Substitution on the Phosphodiesterase Type 4 (PDE4) and TNFα Inhibitory Activity of Two Series of Rolipram Analogues:  Implications for a New Active Site Model of PDE4

Edward F. Kleinman, Erin Campbell, L. GIORDANO et al. · Journal of Medicinal Chemistry · 1998 · 55 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Molecular Sciences +12

The Preclinical Pharmacological Profile of the Potent and Selective Leukotriene B4 Antagonist CP-195543

Henry J. Showell, Maryrose J. Conklyn, Robbin Alpert et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 51 citations